Revisión de nuevas evidencias acerca de la posible transmisión vertical de la COVID-19
Gaceta Sanitaria · 2022-03 · 36 (2) · 166-172
DOI: 10.1016/j.gaceta.2020.06.005 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Gaceta Sanitaria, 2022-03. Verfasst von Clara Luz Sampieri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Salud Pública, Universidad Veracruzana, Xalapa, Veracruz, México. Electronic address: csampieri@uv.mx. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To conduct a systematic review of original peer-reviewed studies, containing data on the identification of SARS-CoV-2 in clinical samples of amniotic fluid, placenta or membranes, umbilical cord blood, and human milk, from women with a clinically or confirmed diagnosis of COVID-19. These studies should have been published after the guide for the management of patients with COVID-19 from World Health Organization guide (available in March 13, 2020).
Results
Seventeen studies were included, in which 143 clinical samples were identified (38 of amniotic fluid; 34 of placentas or membranes; 39 from umbilical cord blood and 32 from human milk). Among the 143 samples, nine were positive for SARS-CoV-2 RNA (one amniotic fluid sample obtained before rupturing the membranes; six samples of placenta or membranes, although authors indicate the possibility of contamination by maternal blood in three of these, and two samples of human milk).
Conclusions
Following our search criteria, we found no studies that demonstrate the detection of SARS-CoV-2, in conjunction with viral isolation and the evaluation of the infective capacity of viral particles, in clinical samples of amniotic fluid, placenta or membranes, umbilical cord blood and human milk, from women with a confirmed or clinical diagnosis of COVID-19. However, vertical transmission cannot be ruled out, larger studies are required that ideally locatein situRNA and protein of SARS-CoV-2, as well as isolation that demonstrate the infective capacity of the viral particles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Salud Pública, Universidad Veracruzana, Xalapa, Veracruz, México. Electronic address: csampieri@uv.mx.
- Instituto de Salud Pública, Universidad Veracruzana, Xalapa, Veracruz, México.
Zitieren
APA
Sampieri, C. L., & Montero, H. (2022). Revisión de nuevas evidencias acerca de la posible transmisión vertical de la COVID-19. Gaceta Sanitaria, 36(2), 166-172. https://doi.org/10.1016/j.gaceta.2020.06.005
Vancouver
Sampieri CL, Montero H. Revisión de nuevas evidencias acerca de la posible transmisión vertical de la COVID-19. Gaceta Sanitaria. 2022;36(2):166-172. doi:10.1016/j.gaceta.2020.06.005
BibTeX
@article{Sampieri2022,
author = {Sampieri, Clara Luz and Montero, Hilda},
title = {Revisión de nuevas evidencias acerca de la posible transmisión vertical de la COVID-19},
journal = {Gaceta Sanitaria},
year = {2022},
volume = {36},
number = {2},
pages = {166--172},
doi = {10.1016/j.gaceta.2020.06.005}
}
EUVIMED